RBM27 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.590400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.191000E-01
Normal-vs-Stage2
8.890800E-01
Normal-vs-Stage3
1.489170E-01
Normal-vs-Stage4
4.385200E-01
Stage1-vs-Stage2
9.294400E-01
Stage1-vs-Stage3
1.585950E-02
Stage1-vs-Stage4
3.191400E-01
Stage2-vs-Stage3
1.258630E-01
Stage2-vs-Stage4
1.183990E-01
Stage3-vs-Stage4
5.162100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.227400E-01
Normal-vs-AfricanAmerican
8.037600E-01
Normal-vs-Asian
7.452600E-01
Caucasian-vs-AfricanAmerican
3.963600E-01
Caucasian-vs-Asian
6.320400E-01
AfricanAmerican-vs-Asian
4.702000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.646400E-01
Normal-vs-Female
8.640400E-01
Male-vs-Female
9.811800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.725200E-01
Normal-vs-Age(41-60Yrs)
7.263600E-01
Normal-vs-Age(61-80Yrs)
6.647000E-01
Normal-vs-Age(81-100Yrs)
4.235600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.860470E-03
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.897800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.439000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.137900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.934100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.901600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.454200E-01
Normal-vs-Daily Drinker
4.001200E-01
Normal-vs-Weekly Drinker
5.500400E-01
Normal-vs-Occasional Drinker
7.989000E-01
Normal-vs-Social Drinker
8.522000E-01
Non Drinker-vs-Daily Drinker
3.994800E-01
Non Drinker-vs-Weekly Drinker
6.102800E-01
Non Drinker-vs-Occasional Drinker
1.536240E-01
Non Drinker-vs-Social Drinker
2.240800E-01
Daily Drinker-vs-Weekly Drinker
8.718600E-01
Daily Drinker-vs-Occasional Drinker
5.024300E-02
Daily Drinker-vs-Social Drinker
8.074100E-02
Weekly Drinker-vs-Occasional Drinker
1.463750E-01
Weekly Drinker-vs-Social Drinker
1.988220E-01
Occasional Drinker-vs-Social Drinker
9.094600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.480000E-02
Normal-vs-Grade 2
2.297700E-02
Normal-vs-Grade 3
9.477100E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.195600E-01
Grade 1-vs-Grade 3
1.363380E-01
Grade 1-vs-Grade 4
6.480000E-02
Grade 2-vs-Grade 3
6.909000E-01
Grade 2-vs-Grade 4
2.297700E-02
Grade 3-vs-Grade 4
9.477100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.565000E-01
Normal-vs-NonDiabetic
7.604800E-01
Diabetic-vs-NonDiabetic
6.478600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.942200E-01
Normal-vs-NoPancreatitis
8.023600E-01
Pancreatitis-vs-NoPancreatitis
4.766800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.598800E-01
Normal-vs-N1
8.802600E-01
N0-vs-N1
9.246400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.221000E-01
Normal-vs-TP53-NonMutant
9.498800E-01
TP53-Mutant-vs-TP53-NonMutant
5.714600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
